• FindA University Ltd Featured PhD Programmes
  • Heriot-Watt University Featured PhD Programmes
  • King Abdullah University of Science and Technology (KAUST) Featured PhD Programmes
  • University of Southampton Featured PhD Programmes
  • University of Birmingham Featured PhD Programmes
  • University College London Featured PhD Programmes
  • University of Manchester Featured PhD Programmes
University of Liverpool Featured PhD Programmes
University of the West of England, Bristol Featured PhD Programmes
Cranfield University Featured PhD Programmes
Coventry University Featured PhD Programmes
University of Liverpool Featured PhD Programmes

Targeting metabolic pathways as an effective strategy to improve vascular and muscular fitness in diabetic peripheral ischaemia

This project is no longer listed in the FindAPhD
database and may not be available.

Click here to search the FindAPhD database
for PhD studentship opportunities
  • Full or part time
    Prof P Madeddu
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

About This PhD Project

Project Description

We propose to test the novel hypothesis that restoring metabolic flexibility of angio-myogenic cells through modulation of PKCβ and/or PPARβ/δ activity will greatly improve the outcome of diabetic vascular disease. In preliminary studies, we have found that diabetes impinges upon key biological functions of human muscular pericytes (MPs), a principal angio-myogenic cell population. We discovered that hyperglycaemia-associated oxidative stress induces PKCβ activity in diabetic MPs leading to phosphorylation of mitochondrial adaptor protein Shc1, isoform p66 (p66Shc), a major regulator of redox homeostasis. Inhibition of PKCβ restores MP proliferation and myogenic differentiation and abrogates diabetic MPs anti-angiogenic activity. These data prompt us to test the therapeutic activity of PKCβ inhibitors in a diabetic animal model of peripheral ischaemia. PKCβ inhibitors will be tested alone or in association with a PPARβ/δ agonist to achieve a global metabolic control. We expect that this combinatory approach will benefit regenerative processes at vascular and muscular level.

When applying please select ’Medicine PhD’ within the Faculty of Health Sciences.

Related Subjects

Share this page:

Cookie Policy    X